Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
N/A Completed N=10

HOP-2A - Intratesticular Hormone Levels

Healthy · Male Infertility · Prostate Disease
Source: ClinicalTrials.gov NCT00756561 ↗
Enrolled (actual)
10
Serious AEs
0.0%
Results posted
Jul 2013
Primary outcomePrimary: Intratesticular Hormones in Normal Men — 486; 3.0; 3.7; 0.20 ng/mL

Summary

The purpose of this investigational study is to find out what hormones are present in healthy male testicles using fine needle aspiration.

Outcome Measures

OutcomeResultp-value
PRIMARY
Intratesticular Hormones in Normal Men		 486; 3.0; 3.7; 0.20; 2.7; 0.025 —

Eligibility Criteria

Inclusion Criteria

  • males between 18 and 50 years of age
  • sperm count greater than 20 million/ml, greater than 50% motility, and greater than 15% normal morphology
  • in good general health based on normal screening evaluation (consisting of a medical history, physical exam, normal sperm count, normal serum chemistry, hematology and baseline T, LH, and FSH levels)
  • body mass index ≥18 and ≤32 kg/m2
  • must agree not to participate in another research study involving drug exposure for the duration of the study

Exclusion Criteria

  • men in poor general health, with abnormal blood results
  • sperm counts <20 million/ml on two tests
  • chronic, ongoing alcohol or drug abuse
  • participation in a long-term male contraceptive study within the past three months
  • history of testicular or scrotal surgery
  • history of infertility
  • abnormal testicular exam
  • abnormal DRE
  • chronic pain syndrome
  • use of steroids, testosterone, or medications which might interfere with androgen metabolism including ketoconazole, glucocorticoids
  • known bleeding disorder
  • use of medications which may affect bleeding time (ongoing aspirin or anti-inflammatory use, coumadin)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00756561). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search